These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22324204)

  • 1. A retrospective study of the natural history of endogenous subclinical hyperthyroidism.
    Poola R; Mathiason MA; Caplan RH
    WMJ; 2011 Dec; 110(6):277-80. PubMed ID: 22324204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations concerning the natural history of subclinical hyperthyroidism.
    Woeber KA
    Thyroid; 2005 Jul; 15(7):687-91. PubMed ID: 16053385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism.
    Das G; Ojewuyi TA; Baglioni P; Geen J; Premawardhana LD; Okosieme OE
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):146-51. PubMed ID: 22283624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
    Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
    Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
    Rosario PW
    Clin Endocrinol (Oxf); 2010 May; 72(5):685-8. PubMed ID: 20447066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
    Lerch M; Meier C; Staub JJ
    Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes.
    Martin FI; Deam DR
    Med J Aust; 1996 Feb; 164(4):200-3. PubMed ID: 8604186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid abnormalities in elderly patients with subclinical hyperthyroidism].
    Caparević Z; Stojanović D; Ilić V; Bojković G; Stojanović M
    Med Pregl; 2003; 56(11-12):564-7. PubMed ID: 15080051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism.
    Vadiveloo T; Donnan PT; Cochrane L; Leese GP
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E1-8. PubMed ID: 20926532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the natural course of subclinical hyperthyroidism.
    Díez JJ; Iglesias P
    Am J Med Sci; 2009 Apr; 337(4):225-32. PubMed ID: 19402203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
    Sgarbi JA; Villaça FG; Garbeline B; Villar HE; Romaldini JH
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.
    Biondi B; Palmieri EA; Fazio S; Cosco C; Nocera M; Saccà L; Filetti S; Lombardi G; Perticone F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4701-5. PubMed ID: 11134131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism.
    Krysiak R; Szkrobka W; Okopien B
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):205-8. PubMed ID: 25658660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of autonomously functioning thyroid nodules with Hashimoto's thyroiditis: study on a large series of patients.
    Ruggeri RM; Campennì A; Sindoni A; Baldari S; Trimarchi F; Benvenga S
    Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):621-7. PubMed ID: 22068555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
    Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
    Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.
    Zingrillo M; Torlontano M; Ghiggi MR; Frusciante V; Varraso A; Liuzzi A; Trischitta V
    Thyroid; 2000 Nov; 10(11):985-9. PubMed ID: 11128727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.